CytoSorbents Corporation (CTSO)

[Rockobongo1281]

From FB:

"Based on our positive data in treating HLH, a close cousin to cytokine release syndrome (CRS) – a common and potentially life-threatening complication of CAR T-cell therapy, an expected approval of Novartis’ therapy later this year could open new paths to fast track approval of CytoSorb in the US."